Eisai, Biogen get US FDA approval for Alzheimer's drug, apply for full approval - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

United States News News

United States United States Latest News,United States United States Headlines

The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the earliest stages of the mind-wasting disease.

FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder/File PhotoFILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder/File Photo

Eisai said the drug would launch at an annual price of $26 500. Biogen shares, which had been halted, were up 3% at $279.40. “The new drug may not generate a significant profit immediately after the launch, but it will start contributing to our profit in the latter half of the second year or the third year,” he said without giving any concrete figure.

“Without Centers for Medicare & Medicaid Services and insurance coverage … access for those who could benefit from the newly-approved treatment will only be available to those who can pay out-of-pocket,” the Alzheimer’s Association said in a statement. If the drug receives traditional FDA approval, CMS said it would provide broader coverage. Eisai officials have said the company plans to submit data from a recent successful clinical trial in 1,800 patients as the basis for a full standard review of Leqembi.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 37. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

They must start giving this wonder to the old anc that keep forgetting what they promise

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US FDA approves Eisai, Biogen Alzheimer's drug - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the earliest stages of the mind-wasting disease. I'm really grateful for all the efforts you have render to me with my little investment of R5000 and with joy over me after withdrawing R60,000 with your help Lisa_berry77 thank you for everything you have done for me and my family Lisa_berry77
Source: SABCNews - 🏆 37. / 51 Read more »

US FDA approves Eisai, Biogen Alzheimer's drug - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the earliest stages of the mind-wasting disease. I'm really grateful for all the efforts you have render to me with my little investment of R5000 and with joy over me after withdrawing R60,000 with your help Lisa_berry77 thank you for everything you have done for me and my family Lisa_berry77
Source: SABCNews - 🏆 37. / 51 Read more »